Program

For information, please contact Nicole Levesque (levesque@hsph.harvard.edu, 617-432-4902)

Register Here!

Monday, May 17, 2021
Virtual Meeting via Zoom and all times below are EDT

8:30 – 8:45 Welcome & Introduction
8:45 – 9:00 Yasmine Belkaid, NIH/NIAID
Opening Remarks
9:00 – 10:00 Maria Gloria Dominguez-Bello, Rutgers University
“The human microbiome in a disruptive era”
10:00 – 10:30 Amy Willis, University of Washington
“Estimating microbial abundances from high-throughput sequencing”
10:30 – 10:45 Caroline Young, University of Leeds
“Screening potential of the CRC-associated microbiome”
10:45 – 11:00 Marissa Bivins, University of North Carolina, Chapel Hill
“Discovery of the Gut Microbial Enzymes that Drive the Dose-Limiting Toxicity of the Immunosuppressant Mycophenolate Mofetil”
11:00 – 11:15 Break
11:15 – 11:45 Liz Johnson, Cornell University
“Dietary lipids as modulators of microbiome function”
11:45 – 12:15 Greg Caporaso, Northern Arizona University
“Accessible and reproducible microbiome multi-omics bioinformatics with QIIME 2”
12:15 – 1:30 Lunch Break
1:30 – 2:00 Dong Daniel Wang, Harvard Medical School, Brigham & Women’s Hospital
“The Gut Microbiome Modifies the Associations between Diet and Cardiometabolic Disease Risk”
2:00 – 2:15 Apollo Stacy, NIH/NIGMS
“Infection trains the host for microbiota-enhanced resistance to pathogens”
2:15 – 2:30 Amrisha Bhosle, Broad Institute & Harvard T.H. Chan School of Public Health
“Prioritization and Annotation of Novel Bioactive Small Molecules from the Microbiome”
2:30 – 2:45 Break
2:45 – 3:15 Elaine Hsiao, University of California, Los Angeles
“Interactions between the microbiome and nervous system during early neurodevelopment”
3:15 – 4:15 Peter Turnbaugh, University of California, San Francisco
“The tiny pharmacists within: how the microbiome impacts the treatment of chronic and infectious diseases”
4:15 – 4:30 Closing Remarks
Poster Reception available online all day here